CRISPR Therapeutics(CRSP.US) Officer Sells US$1.17 Million in Common Stock

$CRISPR Therapeutics(CRSP.US)$ Officer Kulkarni Samarth sold 19,582 shares of common stock on Apr 15, 2024 at an average price of $59.9138 for a total value of $1.17 million.Source: Announcement What

moomoo News18:28 ET

Crispr Therapeutics Insider Sold Shares Worth $1,173,232, According to a Recent SEC Filing

Samarth Kulkarni, Director, Chief Executive Officer, on April 15, 2024, sold 19,582 shares in Crispr Therapeutics (CRSP) for $1,173,232. Following the Form 4 filing with the SEC, Kulkarni has control

MT Newswires17:51 ET

Bullish Trendline Has Never Failed Crispr Therapeutics Stock

Schaeffer's Investment Research12:58 ET

CRISPR Therapeutics AG (CRSP) Stock Sinks As Market Gains: What You Should Know

Yahoo FinanceApr 16 18:00 ET

Estimating The Intrinsic Value Of CRISPR Therapeutics AG (NASDAQ:CRSP)

Key Insights Using the 2 Stage Free Cash Flow to Equity, CRISPR Therapeutics fair value estimate is US$68.64 Current share price of US$58.72 suggests CRISPR Therapeutics is potentially trading close

Simply Wall StApr 16 07:03 ET

TD Cowen Says Sickle Cell Therapies May Get Higher CMS Payments

Seeking AlphaApr 15 16:46 ET